Resources

MyPath Melanoma

Learn about Castle’s comprehensive diagnostic offering

Our suite of objective and highly accurate tests for melanocytic lesions of uncertain potential increases diagnostic confidence and enables better clinical management plans for patients. Learn the essentials from this comprehensive introduction by Matthew Goldberg, MD, Senior Vice President, Medical for Castle Biosciences.

Explore on-demand case study webinars

Listen to multiple clinicians discuss how gene expression profile testing can provide guidance for difficult-to-diagnose lesions and improve patient management.